These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2563937)

  • 1. Protirelin (thyrotropin-releasing hormone) in amyotrophic lateral sclerosis. The role of androgens.
    Miller SC; Warnick JE
    Arch Neurol; 1989 Mar; 46(3):330-5. PubMed ID: 2563937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of amyotrophic lateral sclerosis with thyrotropin-releasing hormone (TRH).
    Yamane K; Osawa M; Kobayashi I; Maruyama S
    Jpn J Psychiatry Neurol; 1986 Jun; 40(2):179-87. PubMed ID: 3097367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic trial of intrathecal thyrotropin-releasing hormone (TRH) and a TRH-analogue in amyotrophic lateral sclerosis (ALS).
    Thielen T; Stober T; Schimrigk K
    Adv Exp Med Biol; 1987; 209():305-8. PubMed ID: 3107352
    [No Abstract]   [Full Text] [Related]  

  • 4. [Spinal mechanism of the antispastic action of TRH in patients with amyotrophic lateral sclerosis].
    Morin C; Pierrot-Deseilligny E
    Rev Neurol (Paris); 1988; 144(11):701-3. PubMed ID: 3148185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender-specific action of thyrotropin-releasing hormone in the mammalian spinal cord.
    Deshpande SB; Pilotte NS; Warnick JE
    FASEB J; 1987 Dec; 1(6):478-82. PubMed ID: 3119415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-response studies with protirelin.
    Garbutt JC; Mayo JP; Little KY; Gillette GM; Mason GA; Dew B; Prange AJ
    Arch Gen Psychiatry; 1994 Nov; 51(11):875-83. PubMed ID: 7944876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrathecal thyrotropin-releasing hormone therapy of amyotrophic lateral sclerosis.
    Stober T; Schimrigk K; Dietzsch S; Thielen T
    J Neurol; 1985; 232(1):13-4. PubMed ID: 3923160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spinal cord electrophysiological activities after small doses of TRH in control subjects and ALS patients.
    Delwaide PJ; Schoenen J
    Adv Exp Med Biol; 1987; 209():129-33. PubMed ID: 3107349
    [No Abstract]   [Full Text] [Related]  

  • 9. Intrathecal thyrotropin-releasing hormone in amyotrophic lateral sclerosis.
    Munsat TL; Taft J; Kasdon D
    Neurol Clin; 1987 Feb; 5(1):159-70. PubMed ID: 3104751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect on weakness and spasticity in amyotrophic lateral sclerosis of thyrotropin-releasing hormone.
    Engel WK; Siddique T; Nicoloff JT
    Lancet; 1983 Jul; 2(8341):73-5. PubMed ID: 6134961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolactin response to growth hormone-releasing hormone during chronic thyrotropin-releasing hormone infusion in the treatment of amyotrophic lateral sclerosis.
    Chiodini PG; Attanasio R; Liuzzi A; Cozzi R; Orlandi P; De Palo C; Dallabonzana D; Girotti F; Testa D
    J Endocrinol Invest; 1990 Sep; 13(8):631-6. PubMed ID: 2125610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained rises in serum thyrotropin, thyroxine, and triiodothyronine during long term, continuous thyrotropin-releasing hormone treatment in patients with amyotrophic lateral sclerosis.
    Kaplan MM; Taft JA; Reichlin S; Munsat TL
    J Clin Endocrinol Metab; 1986 Oct; 63(4):808-14. PubMed ID: 3091628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analog specificity of the thyrotropin-releasing hormone receptor in the central nervous system: possible clinical implications.
    Hawkins EF; Engel WK
    Life Sci; 1985 Feb; 36(6):601-11. PubMed ID: 2982071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged intrathecal infusion of thyrotropin releasing hormone in amyotrophic lateral sclerosis.
    Munsat TL; Taft J; Kasdon D; Jackson IM
    Ann N Y Acad Sci; 1988; 531():187-93. PubMed ID: 3132882
    [No Abstract]   [Full Text] [Related]  

  • 15. Controlled trial of thyrotropin releasing hormone in amyotrophic lateral sclerosis.
    Brooke MH; Florence JM; Heller SL; Kaiser KK; Phillips D; Gruber A; Babcock D; Miller JP
    Neurology; 1986 Feb; 36(2):146-51. PubMed ID: 3080694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neural functions of TRH.
    Reichlin S
    Acta Endocrinol Suppl (Copenh); 1986; 276():21-33. PubMed ID: 3019059
    [No Abstract]   [Full Text] [Related]  

  • 17. [New hormone therapy. Thyrotropin releasing hormone].
    Sobue I
    Nihon Rinsho; 1987 Nov; 45(11):2671-8. PubMed ID: 3127616
    [No Abstract]   [Full Text] [Related]  

  • 18. Concentrations of immunoreactive thyrotropin-releasing hormone in spinal cord of patients with amyotrophic lateral sclerosis.
    Mitsuma T; Nogimori T; Adachi K; Mukoyama M; Ando K
    Am J Med Sci; 1984; 287(2):34-6. PubMed ID: 6424472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of intrathecal thyrotropin-releasing hormone (protirelin) in refractory depressed patients.
    Marangell LB; George MS; Callahan AM; Ketter TA; Pazzaglia PJ; L'Herrou TA; Leverich GS; Post RM
    Arch Gen Psychiatry; 1997 Mar; 54(3):214-22. PubMed ID: 9075462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Segmental synaptic depression caused by diisopropylphosphorofluoridate and sarin is reversed by thyrotropin-releasing hormone in the neonatal rat spinal cord.
    Das Gupta S; Deshpande SB; Warnick JE
    Toxicol Appl Pharmacol; 1988 Sep; 95(3):499-506. PubMed ID: 2847364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.